Cancer of the Prostate Clinical Trial
Official title:
Evaluation of the Accuracy of the Elastic Fusion MRI-ultrasound ((Magnetic Resonance Imaging) Obtained in Vivo by the Koelis™ System
The study aims at quantifying the registration error obtained in routine patients in
different parts of the prostate and for operators with different experience in order to
assess the average precision of the elastic MR-ultrasound fusion obtained by Koelis™ system.
Patients referred for placement of intraprostatic fiducials before radiotherapy for prostate
cancer will be prospectively offered to enter the study.
The fiducials will be placed under transrectal ultrasound guidance, in the prostate apex,
midgland and base, according to our routine procedure. A 3D Ultrasound acquisition of the
prostate will be obtained at the end of the placement. As per our routine procedure,
patients will undergo unenhanced prostate MRI to control the position of the fiducials. An
elastic fusion of the MR images and the 3D ultrasound acquisitions will be retrospectively
performed by operators of varying experience using the Koelis system. The fiducials (visible
on MR and ultrasound images) will be used to quantify the registration error.
n/a
Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03653819 -
High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower Limbs
|
N/A | |
| Withdrawn |
NCT05191017 -
Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC
|
Phase 1/Phase 2 | |
| Completed |
NCT00970203 -
Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer
|
Phase 2 | |
| Not yet recruiting |
NCT06363266 -
A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers
|
N/A | |
| Active, not recruiting |
NCT02003924 -
Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
|
Phase 3 | |
| Completed |
NCT00643617 -
CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
|
N/A | |
| Completed |
NCT00844792 -
Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer
|
Phase 2 | |
| Completed |
NCT01303705 -
Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer
|
Phase 1 | |
| Completed |
NCT02578940 -
Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer
|
Phase 3 | |
| Completed |
NCT04057859 -
PCa Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness Training
|
||
| Completed |
NCT00564928 -
A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer
|
Phase 2 | |
| Completed |
NCT02958787 -
Vessel Sparing Prostate Radiation Therapy
|
Phase 2 | |
| Completed |
NCT01897207 -
Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate Cancer
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05241236 -
MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer
|
||
| Active, not recruiting |
NCT03939689 -
Study of I-131-1095 Radiotherapy in Combination With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer Who Are Chemotherapy Naive and Have Progressed on Abiraterone
|
Phase 2 | |
| Completed |
NCT02274350 -
The Herlev Hospital Post Radiation Therapy for Localized Prostate Cancer Database for Sexual Side Effects
|
N/A | |
| Completed |
NCT00744549 -
Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance
|
Phase 2 | |
| Recruiting |
NCT05252390 -
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT02212548 -
Prostate-Rectal Separation With PEG Hydrogel and Its Effect on Decreasing Rectal Dose
|
N/A | |
| Completed |
NCT04017325 -
European Randomised Study of TOOKAD® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-up
|